Latest: FDA Approves New Biosimilar for Oncology Treatment

INA President’s Message | Sept. 2025

0 Mins
Dear INA Members, As we move through another eventful quarter, I want to extend my appreciation for your ongoing dedication to our patients, our communities, and the future of our profession. It is a complex time, and your leadership matters more than ever. Legislative Spotlight: The One Big Beautiful Bill (OBBB) and Medicaid Implications The...
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago